| Rosacea
Mirvaso vs Rhofade
Side-by-side clinical, coverage, and cost comparison for rosacea.Deep comparison between: Mirvaso vs Rhofade with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsRhofade has a higher rate of injection site reactions vs Mirvaso based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Rhofade but not Mirvaso, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Mirvaso
Rhofade
At A Glance
Topical
Once daily
Alpha-2 adrenergic agonist
Topical
Daily
Alpha-1A adrenoceptor agonist
Indications
- Rosacea
- Rosacea
Dosing
Rosacea Apply a pea-sized amount once daily to each of the five areas of the face (central forehead, chin, nose, each cheek) as a thin layer across the entire face, avoiding the eyes and lips; wash hands after applying.
Rosacea Apply a pea-sized amount once daily in a thin layer to cover the entire face (forehead, nose, each cheek, and chin), avoiding the eyes and lips; wash hands immediately after applying.
Contraindications
- Hypersensitivity reaction to any component of MIRVASO topical gel (reactions have included angioedema, urticaria, and contact dermatitis)
—
Adverse Reactions
Most common (>=1%) Erythema, flushing, skin burning sensation, contact dermatitis, dermatitis, skin warmth, paraesthesia, acne, skin pain, blurred vision, nasal congestion
Postmarketing Bradycardia, hypotension, angioedema, hypersensitivity, lip swelling, swollen tongue, throat tightness, urticaria, dizziness, pallor
Most common (>=1%) application site dermatitis, worsening inflammatory lesions of rosacea, application site pruritus, application site erythema, application site pain
Pharmacology
Brimonidine is a relatively selective alpha-2 adrenergic agonist; topical application of MIRVASO topical gel may reduce facial erythema through direct vasoconstriction.
Oxymetazoline is an alpha 1A adrenoceptor agonist that acts as a vasoconstrictor when applied topically to the face.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Mirvaso
- Covered on 5 commercial plans
- PA (10/12) · Step Therapy (5/12) · Qty limit (0/12)
Rhofade
- Covered on 5 commercial plans
- PA (9/12) · Step Therapy (6/12) · Qty limit (9/12)
UnitedHealthcare
Mirvaso
- Covered on 4 commercial plans
- PA (6/8) · Step Therapy (0/8) · Qty limit (0/8)
Rhofade
- Covered on 4 commercial plans
- PA (5/8) · Step Therapy (0/8) · Qty limit (1/8)
Humana
Mirvaso
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (1/3) · Qty limit (0/3)
Rhofade
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (2/3) · Qty limit (3/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Mirvaso.
No savings programs available for Rhofade.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
MirvasoView full Mirvaso profile
RhofadeView full Rhofade profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.